SecBot SecBot

CTY

CITY THERAPEUTICS, INC.
Nasdaq· CIK 0002143850 Biotech & Drug Discovery
$20.79 +0.02 (+0.10%)
Oct 26 4:00 PM ET · prev $20.77
Market cap
$1.0B
Small cap
Since first trade
−7.2%
from $22.40 · Oct 16
30 days
−7.2%
from $22.40
Range since listing
$20.43–22.40
−7% from high · low Oct 21
Avg volume 7D
461.7K
Oct 16 spike 1.41M
Insider net
+$6.1M
2 buyers · 0 sellers · 12 mo
Filing reports
17
analyzed by SecBot
SecBot read MIXED 18 reports · 90 days
Balance 0 bearish · 1 bullish · 17 neutral oldest → newest, height = score
Avg score ·High conf. 15/18
Strongest BULLISH Two 10% owners, including director Robert Nelsen and ARCH Venture Partners XII, LLC, each purchased 170,000…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersBULLISH

    2 insiders bought $6.1M at an average $18.00. No open-market sales. Price is 16% above their cost.

Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 26, 2026 SEC
🔒 Fresh report (last 24h), subscribers only
Oct 26, 2026 SEC
🔒 Fresh report (last 24h), subscribers only
Oct 22, 2026 SEC
Invus Global Management, LLC and affiliated entities filed a Schedule 13G disclosing a passive 8.1% stake in City…
SC 13G — Impact 3/10
Oct 19, 2026 Press
City Therapeutics closed its upsized IPO of 12,777,777 shares at $18.00 per share, raising approximately $230 million…
Impact 5/10
Oct 19, 2026 Activist
City Therapeutics Announces Closing of $230.0 Million Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
City Therapeutics Announces Closing of $230.0 Million Upsized Initial Public Offering, Including Ful
Oct 19, 2026 Insider
ORTH ANDREW C. was granted 77,979 shares
President & CEO
Oct 19, 2026 Insider
MARAGANORE JOHN acquired 610,759 shares
Director
Oct 19, 2026 Insider
MARAGANORE JOHN disposed of 500,000 shares
Director

Insider ledger

Form 4
$6.1M
bought · 2 insiders
$0
sold · 0 insiders
+15.5%
vs their $18.00 cost
DateInsiderTypeValue
Oct 19, 2026
ORTH ANDREW C.
President & CEO
AWARD77,979 sh
Oct 19, 2026
MARAGANORE JOHN
Director
CONVERT610,759 sh
Oct 19, 2026
MARAGANORE JOHN
Director
CONVERT500,000 sh
Oct 19, 2026
MARAGANORE JOHN
Director
CONVERT56,095 sh
Oct 19, 2026
ARCH Venture Partners XII, LLC
10%+ Owner
CONVERT3,294,900 sh
Oct 19, 2026
ARCH Venture Partners XII, LLC
10%+ Owner
CONVERT5,482,309 sh
Oct 19, 2026
ARCH Venture Partners XII, LLC
10%+ Owner
CONVERT2,027,006 sh
Oct 19, 2026
ARCH Venture Partners XII, LLC
10%+ Owner
BUY$3.1M

Earnings setup

Estimates
PeriodEPS est.Range30D rev.Revenue
Current Q———$0.00
Next Q———$0.00
Current FY———$0.00
Next FY———$0.00
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Oct 19, 2026
Activist
City Therapeutics Announces Closing of $230.0 Million Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
City Therapeutics Announces Closing of $230.0 Million Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase...
Oct 16, 2026
Listing
New Listing: CTY — City Therapeutics, Inc. - Common Stock
Listed on exchange Q

SecBot reports

17 filings · 1 press release · 1 bullish · 0 bearish · 16 neutral
All CTY filing & press-release reports (18)